IQVIA

IQVIA is a leading provider of data, analytics and clinical research services to the pharmaceutical and healthcare industries. Formed from the merger of Quintiles and IMS Health, it helps drugmakers run clinical trials and mine vast troves of health data, giving it a central role in how new medicines are developed and commercialized. IQVIA pays no dividend, directing its cash flow toward acquisitions, debt reduction and share buybacks instead. This makes it a growth-oriented holding rather than an income vehicle, and its low dividend score reflects the absence of a payout. Investors are drawn by the company's scale in healthcare data and contract research rather than by any distribution, and should not expect income here.